13F filing recap · Q2 2009

What did Cantillon Capital Management buy in Q2 2009?

Reported stock-position changes between this filing and the previous one.

Stock value

$762.63M

Positions

Estimated turnover

99.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

COVCovidien Plc$84.20Mreported value+2.25M shares TRVTravelers Companies, Inc.$48.49Mreported value+1.18M shares CLColgate-Palmolive Company$34.82Mreported value+492.2K shares PDCOPatterson Companies Inc$23.27Mreported value+1.07M shares ACNAccenture Plc$16.14Mreported value+482.5K shares

Increased positions

SNNSmith & Nephew Plc$6.94Mreported value+50.0K shares+36.7%

Reduced positions

BDXBecton Dickinson & Co$115.78Mreported value-245.6K shares-13.1%PGProcter & Gamble Co$97.33Mreported value-872.7K shares-31.4%CAGConagra Brands, Inc.$77.56Mreported value-1.31M shares-24.4%CBChubb Limited$76.15Mreported value-510.6K shares

Exited positions

KRKroger Co$128.22Mprior reported value-6.04M shares-100.0%TMOThermo Fisher Scientific Inc.$113.35Mprior reported value-3.18M shares-100.0%COVCovidien Ltd$101.62Mprior reported value-3.06M shares-100.0%ALCAlcon Inc.$64.09Mprior reported value-704.9K shares